Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2009 Mar;112(3):583-9.
doi: 10.1016/j.ygyno.2008.11.013. Epub 2008 Dec 24.

Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

Leslie M Randall  1 , Bradley J Monk, Kathleen M Darcy, Chunqiao Tian, Robert A Burger, Shu-Yuan Liao, William A Peters, Richard J Stock, John P Fruehauf
Affiliations
Clinical Trial

Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study

Leslie M Randall et al. Gynecol Oncol. 2009 Mar.

Abstract

Objectives: To determine whether markers of tumor angiogenesis were associated with progression-free survival (PFS) and overall survival (OS) in women with high-risk, early-stage cervical cancer treated on a phase III trial.

Methods: One hundred seventy-three tumor specimens were analyzed by semi-quantitative immunohistochemical (IHC) staining for vascular endothelial growth factor (VEGF, pro-angiogenesis factor), thrombospondin-1 (TSP-1, anti-angiogenesis factor), CD31 (non-specific endothelial marker), and CD105 (tumor-specific endothelial marker). Tumoral histoscores (HS) were calculated for VEGF using the formula: [% cells positivex(intensity+1)]. TSP-1 specimens were categorized as negative or positive. CD31 and CD105 microvessel density (MVD) "hotspots" were counted in three 20x high-power fields. Associations between angiogenesis markers and survival were evaluated.

Results: TSP-1 expression was observed in 65% of cases while 66% expressed high VEGF (>or=200), 34% exhibited high CD31 (CD31>or=110) and 66% displayed high CD105 (CD105>or=28). In univariate analyses CD31 MVD, but not tumor TSP-1, was associated with improved PFS (HR=0.37; 95% CI=0.18-0.76; p=0.007) and OS (HR=0.37; 95% CI=0.17-0.79; p=0.010). After adjusting for prognostic clinical covariates, high CD31 MVD, but not TSP-1, VEGF or CD105 MVD, was an independent prognostic factor for PFS (HR=0.36; 95% CI=0.17-0.75; p=0.006) and OS (HR=0.36; 95% CI=0.17-0.79; p=0.010).

Conclusions: Tumor angiogenesis measured by CD31 MVD is an independent prognostic factor for both PFS and OS in high-risk, early-stage cervical cancer. We hypothesize that this finding may be explained by improved treatment response in well-vascularized, well-oxygenated tumors.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Kaplan–Meier plots for progression-free survival (A, C, E, G) and overall survival (B, D, F, H) for women categorized by CD31 MVD (A, B), stromal TSP-1 expression (C, D), VEGF histoscore (E, F) or CD105 MVD (G, H).
See this image and copyright information in PMC

References

    1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:4–10. - PubMed
    1. Ries LAG, Melbert D, Krapcho M. SEER cancer statistics review, 1975–2004. National Cancer Institute; Bethesda, MD: ( http://seer.cancer.gov/csr/1975_2004/, based on November 2006 SEER data submission, posted to the SEER web site, 2007)
    1. Delgado G, Bundy B, Zaino R, et al. Prospective surgical–pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990;38:352–7. - PubMed
    1. Monk BJ, Wang J, Im S, et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol. 2005;96:721–8. - PubMed
    1. Im SS, Wilczynski SP, Burger RA, et al. Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion. Clin Cancer Res. 2003;9:4145–50. - PubMed

Publication types

MeSH terms